Evofem Biosciences, Inc.
EVFM- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001618835
No open-market purchases or sales by Evofem Biosciences, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Evofem Biosciences, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 63 | 68 | +5 |
| Shares | 23.6M | 19.7M | −3.86M (−16.4%) |
| Value | $8.84M | $6.66M | −$2.18M (−24.7%) |
New holders (11)
Institutions that held Evofem Biosciences, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tocqueville Asset Management L.P. | 51,060 | $17.0K | 0.00% |
| Bayesian Capital Management, LP | 35,900 | $12.0K | 0.00% |
| LPL Financial LLC | 26,252 | $9.00K | 0.00% |
| Two Sigma Securities, LLC | 17,944 | $6.00K | 0.00% |
| Bank of Montreal | 10,000 | $4.00K | 0.00% |
| Journey Strategic Wealth LLC | 10,000 | $3.00K | 0.00% |
| Citigroup Inc | 2,500 | $1.00K | 0.00% |
| IFP Advisors, Inc | 30 | $1.00K | 0.00% |
| FMR LLC | 28 | $0 | 0.00% |
| Joseph P. Lucia & Associates, LLC | 11 | $0 | 0.00% |
| Tyler-Stone Wealth Management | 231 | $0 | 0.00% |
Sold out (6)
Institutions that held Evofem Biosciences, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Baker Bros. Advisors LP | 2,697,110 | $1.01M |
| Gsa Capital Partners LLP | 924,781 | $347.0K |
| Virtu Financial LLC | 260,065 | $98.0K |
| Spire Wealth Management | 13,000 | $5.00K |
| Wagner Wealth Management, LLC | 34 | $0 |
| Widmann Financial Services, Inc. | 2 | $0 |